Objects
Wilcken, Nicholas, Zdenkowski, Nicholas, Chua, Sue, Chirgwin, Jacquie, Beith, Jane, Bell, Richard, White, Michelle, Snyder, Ray, Pittman, Ken, Mainwaring, Paul, Green, Michael, Francis, Prudence, De Boer, Richard, Colosimo, Maree. Wiley-Blackwell Publishing; 2014. Systemic treatment of HER2-positive metastatic breast cancer: a systematic review.
Zdenkowski, Nicholas, Butow, Phyllis, Spillane, Andrew, Douglas, Charles, Snook, Kylie, Jones, Mark, Oldmeadow, Christopher, Fewster, Sheryl, Beckmore, Corinna, Boyle, Frances M.. Churchill Livingstone; 2019. Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer.
Herrmann, Anne, Hall, Alix, Sanson-Fisher, Rob, Zdenkowski, Nicholas, Watson, Rochelle, Turon, Heidi. Wiley-Blackwell; 2018. Not asking cancer patients about their preferences does make a difference. A cross-sectional study examining cancer patients' preferred and perceived role in decision-making regarding their last important cancer treatment.
Zdenkowski, Nicholas, Butow, Phyllis, Spillane, Andrew, Douglas, Charles, Snook, Kylie, Jones, Mark, Oldmeadow, Christopher, Fewster, Sheryl, Beckmore, Corianna, Boyle, Francis M.. Harborside Press; 2018. Single-arm longitudinal study to evaluate a decision aid for women offered Neoadjuvant systemic therapy for operable breast cancer.
Zdenkowski, Nicholas, Butow, Phyllis, Hutchings, Elizabeth, Douglas, Charles, Coll, Joseph R., Boyle, Frances M.. JMIR Publications; 2016. A decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer: development and protocol of a phase II evaluation study (ANZ1301 DOMINO).
De Boer, Richard, Beith, Jane, Zdenkowski, Nicholas, Bell, Richard, Chirgwin, Jacquie, Chua, Sue, Colosimo, Maree, Francis, Prudence, Green, Michael, Pittman, Ken, White, Michelle, Wilcken, Nicholas. Wiley-Blackwell Publishing; 2014. Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives.
Luigjes-Huizer, Yvonne L., Tauber, Nina M., Bell, Katy J. L., Custers, José A. E., de Wit, Niek J., Fisher, Peter L., Galica, Jacqueline, Garland, Sheila N., Helsper, Charles W., Jeppesen, Mette M., Liu, Jianlin, Mititelu, Roxana, Humphris, Gerry, Monninkhof, Evelyn M., Russell, L, Savard, J, Speckens, AEM, van Helmondt, SJ, Vatandoust, S, Zdenkowski, Nicholas, van der Lee, ML, Kasparian, Nadine A., Lam, Wendy W. T., Lebel, Sophie, Simard, Sébastien, Smith, Allan Ben, Zachariae, Robert, Afiyanti, Yati. John Wiley & Sons; 2022. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.
Zhou, Meirong, Wang, Shouman, Wang, Jianguo, Cao, Hong, Xu, Haifan, Dai, Bin, Tang, Peizhi, Qian, Liyuan, Zhao, Xi, Xiao, Jun, Zhou, Huaiying, Hu, Jinhui, Wan, Nengbin, Ding, Li, Tripodi, D, Zdenkowski, Nicholas, O'Keefe, TJ, Sanchez, AM, Chen, L, Zhang, P, Xu, F, Yuan, Songlin, Hu, Xiongqiang, Zhou, Wei, Qing, Bohua, Liu, Mingwen, Sun, Weihua, Fan, Peizhi. AME Publishing; 2022. Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.
Jiang, Michael, Avery, Kerry, MacKenzie, Mairead, Meyn, Anne, Poulakaki, Fiorita, Richardson, Andrea L., Sepulveda, Karla, Spillane, Andrew, Thompson, Alastair M., Werutsky, Gustavo, Wright, Jean L., Zdenkowski, Nicholas, Ahmed, Rosina, Cowan, Katherine, McIntosh, SA, Potter, S, de Boniface, Jana, Chatterjee, Sanjoy, Dodwell, David, Dubsky, Peter, Finestone, Sandy, Iwata, Hiroji, Lee, Han-Byoel. Elsevier; 2024. Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.
Cuzick, Jack, Chu, Kim, Cummings, Steve, Dowsett, Mitch, Keevil, Brian, Brentnall, Adam R., Howell, Anthony, Zdenkowski, Nicholas, Bonanni, Bernardo, Loibl, Sibylle, Holli, Kaija, Evans, D. Gareth. Lancet Publishing Group; 2024. Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.